Nexalin Operating Cycle from 2010 to 2024

NXLIW Stock  USD 0.41  0.19  31.67%   
Nexalin Technology Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle is likely to outpace its year average in 2024. During the period from 2010 to 2024, Nexalin Technology Operating Cycle regression line of quarterly data had mean square error of  368,292 and geometric mean of  112.93. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
2.3 K
Current Value
2.4 K
Quarterly Volatility
786.20385581
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nexalin Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexalin Technology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 K, Interest Expense of 54.4 K or Selling General Administrative of 4 M, as well as many indicators such as Price To Sales Ratio of 25.55, Dividend Yield of 0.0 or PTB Ratio of 0.98. Nexalin financial statements analysis is a perfect complement when working with Nexalin Technology Valuation or Volatility modules.
  
Check out the analysis of Nexalin Technology Correlation against competitors.
For more information on how to buy Nexalin Stock please use our How to Invest in Nexalin Technology guide.

Latest Nexalin Technology's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Nexalin Technology over the last few years. It is Nexalin Technology's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexalin Technology's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Nexalin Operating Cycle Regression Statistics

Arithmetic Mean407.21
Geometric Mean112.93
Coefficient Of Variation193.07
Mean Deviation529.86
Median46.14
Standard Deviation786.20
Sample Variance618,117
Range2.3K
R-Value0.67
Mean Square Error368,292
R-Squared0.45
Significance0.01
Slope117.50
Total Sum of Squares8.7M

Nexalin Operating Cycle History

2024 2366.12
2023 2253.45
2022 156.48
2021 575.99
2020 294.69

About Nexalin Technology Financial Statements

Nexalin Technology investors use historical fundamental indicators, such as Nexalin Technology's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nexalin Technology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle2.3 K2.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nexalin Stock Analysis

When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.